WuXi XDC's shares surged since IPO in "honeymoon period".Share price new highs are worth looking forward to unless the short-term logic is falsified. This is when investors need to re-examine WuXi XDC
Boomeranged on Mon, 4 Dec 2023 09:01
Last Friday, WuXi XDC's share price hit new high, and that is just the beginning. AbbVie pays US$10B to acquire ImmunoGen indicates that ADC remains a hot field and important R&D direction for pharmaceutical companies at this stage. As analyzed in the insight, share price could hit new highs again in the future as positive logic is hard to be falsified in short term. Pullback is buying opportunity